tradingkey.logo
tradingkey.logo
Suchen

STAAR Surgical Co

STAA
Zur Watchlist hinzufügen
32.070USD
+0.060+0.19%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
1.59BMarktkapitalisierung
VerlustKGV TTM

STAAR Surgical Co

32.070
+0.060+0.19%

mehr Informationen über STAAR Surgical Co Unternehmen

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Co Informationen

BörsenkürzelSTAA
Name des UnternehmensSTAAR Surgical Co
IPO-datumFeb 24, 1992
CEOFarrell (Stephen C)
Anzahl der mitarbeiter1157
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 24
Addresse1911 Walker Ave
StadtMONROVIA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl91016
Telefon16263037902
Websitehttps://www.staar.com/
BörsenkürzelSTAA
IPO-datumFeb 24, 1992
CEOFarrell (Stephen C)

Führungskräfte von STAAR Surgical Co

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
53.33K
-6.47%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
23.32K
-7.20%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
53.33K
-6.47%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
23.32K
-7.20%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Others
93.84M
39.19%
China
77.78M
32.48%
Japan
45.27M
18.90%
U. S.
22.56M
9.42%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Thu, May 14
Aktualisiert: Thu, May 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Broadwood Capital, Inc.
32.38%
BlackRock Institutional Trust Company, N.A.
13.44%
Yunqi Capital Limited
6.54%
Madison Avenue Partners LP
5.73%
Magnetar Capital Partners LP
4.97%
Andere
36.94%
Aktionäre
Aktionäre
Anteil
Broadwood Capital, Inc.
32.38%
BlackRock Institutional Trust Company, N.A.
13.44%
Yunqi Capital Limited
6.54%
Madison Avenue Partners LP
5.73%
Magnetar Capital Partners LP
4.97%
Andere
36.94%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
53.68%
Investment Advisor
31.49%
Investment Advisor/Hedge Fund
21.11%
Research Firm
6.23%
Pension Fund
1.00%
Individual Investor
0.66%
Bank and Trust
0.36%
Venture Capital
0.06%
Insurance Company
0.02%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
543
58.06M
116.62%
-10.58M
2025Q4
536
52.38M
105.30%
-16.01M
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Broadwood Capital, Inc.
16.12M
32.56%
+670.21K
+4.34%
Mar 13, 2026
BlackRock Institutional Trust Company, N.A.
6.69M
13.51%
+107.78K
+1.64%
Dec 31, 2025
Yunqi Capital Limited
3.26M
6.58%
+750.00K
+29.91%
Jan 14, 2026
Magnetar Capital Partners LP
2.47M
4.99%
+1.27M
+105.28%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.97M
3.98%
+1.11M
+128.32%
Dec 31, 2025
State Street Investment Management (US)
1.94M
3.92%
+29.50K
+1.54%
Dec 31, 2025
Balyasny Asset Management LP
1.54M
3.11%
-272.35K
-15.02%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
Mehr Anzeigen
AltShares Merger Arbitrage ETF
Anteil2.71%
ProShares Merger ETF
Anteil2.53%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.67%
NYLI Merger Arbitrage ETF
Anteil0.87%
Invesco S&P SmallCap Health Care ETF
Anteil0.79%
Royce Quant Small-Cap Quality Value ETF
Anteil0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
Anteil0.13%
iShares S&P Small-Cap 600 Growth ETF
Anteil0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
Anteil0.1%
iShares ESG Select Screened S&P Small-Cap ETF
Anteil0.1%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI